Stay updated on Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments observed on the Study Details page; no changes to core content such as study purpose, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:10:26.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    3%
    Check dated 2025-10-06T05:37:06.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:40.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed as a minor UI tweak.
    Difference
    0.2%
    Check dated 2025-09-14T19:17:35.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T15:42:53.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations in China, as well as a detailed publication related to trastuzumab emtansine. Notably, some previous terms and related topics have been removed.
    Difference
    12%
    Check dated 2025-08-31T11:55:57.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial page.